TP-0469711

N/A

Report date: 2025/01/26 15:37:49
NME

Base Information

Drug NameTP-0469711
Drug Alias NameNa+/H+ exchanger 3 inhibitor (Taisho)TP-0469711
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium/hydrogen exchanger 3 inhibitors
TargetsSodium/hydrogen exchanger 3
Therapy Area/IndicationsHyperphosphatemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTaisho Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTaisho Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHyperphosphatemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A